semaglutide gastrointestinal obstruction legal team in louisiana Ozempic Lawsuit semaglutide gastrointestinal obstruction attorney in

Bottom line Eli Lilly and Companys licensing deal for Hanmi Pharmaceuticalss sonefpeglutide adds a potentially differentiated GLP-2 therapy with total deal value reaching $1.26 billion

Gynecomastia vs fat comes down to one key distinction: true glandular breast tissue caused by hormonal imbalance versus soft excess chest fat related to overall weight gain

GLP-1s account for 23% of first line diabetes therapy in 2025 up from 3% in 2021 Since 2019, the American Diabetes Association (ADA) has revised its Standards of Care each year to expand the role of GLP-1 receptor agonists and SGLT2 inhibitors as first-line treatments for T2D2

/CNW/ - Novo Nordisk announced today that Wegovy (semaglutide injection) is now approved to reduce the risk of non-fatal myocardial infarction in adults with...

The unchanged US$9.88 fair value estimate for LifeMD keeps the core price target steady, even as model inputs see only marginal tweaks